Luc Truyen

Chief Tech/Sci/R&D Officer at ARGENX SE

Net worth: 2 M $ as of 2026-07-30

61 year

Health Technology

Consumer Services

Profile

Dr. Luc Truyen is a Chief Medical Officer at argenx SE.
Dr. Truyen was previously employed as a Chief Marketing Officer & Head-R&D by Janssen Alzheimer Immunotherapy and a Head-Research & Development by Johnson & Johnson Pharmaceutical Group.
He received his doctorate degree from the University of Antwerp.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ARGENX SE 0%	2026-02-18	2,241 ( 0% )	2 M $	2026-07-30

Luc Truyen active positions

Companies	Position	Start
ARGENX SE	Chief Tech/Sci/R&D Officer	2022-03-31

All active positions of Luc Truyen

Former positions of Luc Truyen

Companies	Position	End
Johnson & Johnson Pharmaceutical Group	Chief Tech/Sci/R&D Officer	-
Janssen Alzheimer Immunotherapy Janssen Alzheimer Immunotherapy Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Janssen Alzheimer Immunotherapy is an American company. The company is located in the US.	Sales & Marketing	-

See the detail of Luc Truyen's experience

Training of Luc Truyen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Luc Truyen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
argenx SE argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases	Health Technology
Johnson & Johnson Pharmaceutical Group
Janssen Alzheimer Immunotherapy Janssen Alzheimer Immunotherapy Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Janssen Alzheimer Immunotherapy is an American company. The company is located in the US.	Health Technology
University of Antwerp University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services